ArticleParasites & vectors2026
Serological and molecular positivity for Leishmania infantum in dogs referred to two veterinary hospitals in Barcelona, Spain.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeishmania infantum is endemic in the Mediterranean basin, with dogs serving as the primary domestic reservoir for human infection. Although the city of Barcelona has historically been considered a low-risk area, recent environmental and demographic changes may favor parasite transmission. This study aimed to estimate and compare the positivity to L. infantum using serological and molecular methods in dogs referred to a veterinary hospital in the city of Barcelona (urban) and to another located in its residential metropolitan area (peri- urban), and to assess potential associated risk factors.
methodsA cross-sectional study was conducted from September 2022 to September 2023 at two veterinary referral hospitals in the urban (hospital A) and peri-urban (hospital B) areas of Barcelona. Blood and conjunctival swab samples were analyzed by quantitative ELISA and qPCR targeting L. infantum kinetoplast DNA.
resultsA total of 189 client-owned dogs were enrolled (77 from hospital A and 112 from hospital B). Of these, 93/189 (49.2%) were presented for an annual check-up and appeared healthy, while 96/189 (50.8%) were sick. Leishmania infantum infection-defined as positivity by ELISA and/or qPCR-was detected in 10.6% (20/189) dogs, exclusively among sick patients (20/96;20.8%). None of the healthy dogs tested positive. Both serological and molecular tests yielded a 6.3% (12/189) positivity. All qPCR-positive dogs belonged to hospital B, resulting in a higher positivity rate among dogs referred to the peri-urban hospital (15.2%) than among those referred to the urban hospital (3.9%). Significant associations were identified between positivity and both clinical status (P < 0.001) and hospital location (P = 0.013), but not with the other variables evaluated.
conclusionThe findings confirm active L. infantum transmission among dogs in Barcelona, with higher positivity among dogs referred to a hospital in the peri-urban area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.